Opioid Withdrawal Timeline — Symptoms, Duration, and Treatment
Opioid withdrawal is rarely fatal but is intensely uncomfortable — and the period immediately after withdrawal carries the highest overdose risk of any point in addiction. Understanding the timeline helps you or a loved one prepare for medically supervised detox and make informed decisions about step-down care. Hope Harbor is available 24/7 in Cherry Hill, NJ at (732) 523-5239.
Short-Acting Opioid Withdrawal
Short-acting opioids — heroin, oxycodone (OxyContin, Percocet), hydrocodone (Vicodin), morphine, and codeine — clear the body relatively quickly, producing the most intense but also the most condensed withdrawal timeline.
Onset: 8–24 Hours After Last Use
Early symptoms begin 8–24 hours after the last dose of a short-acting opioid. Initial signs include: excessive yawning, tearing (lacrimation) and runny nose (rhinorrhea), anxiety and restlessness, mild muscle aches, goosebumps (piloerection), and early insomnia.
Peak: 36–72 Hours
Peak intensity typically arrives between 36 and 72 hours. Full symptom profile during peak: severe muscle and bone aches, abdominal cramping and diarrhea, nausea and vomiting (often simultaneous — a major dehydration risk), profuse sweating with cold chills, goosebumps, severe insomnia, depression and anxiety, and intense, overwhelming drug cravings. Most people describe peak opioid withdrawal as a severe flu combined with profound psychological distress. It is rarely life-threatening but is severely debilitating.
Resolution: Days 5–7
Acute symptoms begin to subside by days 5–7 for most short-acting opioids. Physical symptoms — nausea, vomiting, diarrhea, severe muscle aches — resolve first. Sleep begins to return, though disrupted sleep can persist for weeks. Depression and low energy are often the most persistent symptoms as acute withdrawal ends and the post-acute phase begins.
Long-Acting Opioid Withdrawal
Long-acting opioids — methadone and extended-release buprenorphine — produce a different withdrawal profile due to their extended half-lives and prolonged receptor binding.
Methadone Withdrawal
Methadone's half-life (24–36 hours, sometimes longer) means withdrawal onset is delayed to 36–72 hours after the last dose. The peak arrives more gradually and is generally less intense than short-acting opioid peak withdrawal — but the duration is significantly longer, often extending 3–4 weeks with meaningful symptoms. The prolonged nature of methadone withdrawal is a key clinical consideration in detox planning. Slow taper protocols are often preferred over abrupt cessation.
Buprenorphine Withdrawal
Full buprenorphine (Subutex) withdrawal is uncommon in clinical practice — most patients are transitioned to lower doses rather than abruptly discontinued. When withdrawal does occur, the onset is 24–48 hours after the last dose, with a prolonged, relatively mild symptom profile that can extend 2–4 weeks. The partial agonist nature of buprenorphine means its withdrawal is generally milder than full agonist opioids at equivalent doses.
Fentanyl Withdrawal
Fentanyl's unique pharmacological profile — extreme potency and significant lipophilicity (fat solubility) — produces a withdrawal syndrome that is often more prolonged than expected from a nominally "short-acting" opioid. Because fentanyl accumulates in fat and muscle tissue during chronic use, withdrawal onset can be delayed and the acute phase extended beyond the typical heroin withdrawal timeline.
An important additional factor in New Jersey's current drug supply: most fentanyl sold in Camden County and throughout South Jersey is now contaminated with xylazine — a veterinary sedative with its own physical dependence and withdrawal syndrome not reversed by naloxone. See our dedicated fentanyl withdrawal symptoms and timeline page for a full breakdown of xylazine-complicated fentanyl withdrawal.
The Post-Detox Danger Window
This is the most critical safety information on this page: the week immediately following detox discharge is the statistically most dangerous period in opioid addiction — not the withdrawal itself.
Here is why: opioid tolerance collapses rapidly during withdrawal. A person who was using 100mg of oxycodone daily before treatment may have tolerance equivalent to a naive user within 5–7 days of detox. If that person returns to using their pre-treatment dose — even a dose that felt "normal" before — the result can be respiratory depression and death.
This is why overdose rates spike in the days and weeks following:
- Discharge from detox or residential treatment
- Release from incarceration (a form of forced detox)
- Any period of forced or voluntary abstinence followed by return to use
The clinical response to this danger window is immediate step-down to structured programming — PHP (partial hospitalization) or IOP (intensive outpatient) — following detox discharge, combined with continuation of medication-assisted treatment (MAT). This is not optional programming — it is the bridge across the highest-risk period in recovery. See our aftercare programs in South Jersey for continued recovery support.
How Medically Supervised Opioid Detox Works
Hope Harbor's medically supervised opioid detox protocol is designed to minimize discomfort, prevent dangerous complications, and position patients for successful transition into ongoing treatment:
- Buprenorphine (Suboxone) induction: The most effective tool for managing opioid withdrawal. When initiated at the right clinical moment — when the patient has entered moderate withdrawal (COWS score of 8 or higher) — buprenorphine eliminates most acute withdrawal symptoms within 30–60 minutes. The timing of induction is critical and managed by our medical staff. Buprenorphine can be continued as long-term MAT if clinically appropriate.
- Clonidine for autonomic symptoms: An alpha-2 adrenergic agonist that reduces sweating, chills, anxiety, elevated heart rate, and blood pressure associated with opioid withdrawal — particularly useful for patients who are not candidates for buprenorphine induction.
- Anti-nausea medication: Ondansetron (Zofran) to manage nausea and prevent vomiting-related dehydration.
- Anti-diarrheal medication: Loperamide (Imodium) to reduce diarrhea and GI cramping, preventing dehydration and electrolyte loss.
- Non-opioid sleep support: Trazodone, hydroxyzine, or other non-controlled sleep aids to address the insomnia that is consistently one of the most distressing withdrawal symptoms.
- Hydration: Oral or IV fluid replacement as needed based on GI loss and clinical presentation.
- 24/7 clinical monitoring: Vital signs, COWS scoring, comfort assessment, and immediate response to complications throughout the acute phase.
Post-Acute Withdrawal Syndrome (PAWS)
After the acute physical withdrawal phase resolves, a significant percentage of people with opioid use disorder experience a protracted syndrome of neurological readjustment — PAWS. This occurs because chronic opioid use produces lasting changes in the brain's reward circuitry, stress response system, and prefrontal executive function that do not reverse immediately when the drug is removed.
PAWS symptoms in opioid recovery typically include:
- Intense, unpredictable drug cravings — often triggered by stress, emotional states, or environmental cues associated with prior use
- Persistent sleep disruption — difficulty falling asleep, fragmented sleep, vivid using dreams
- Depression and anhedonia — difficulty experiencing pleasure from previously enjoyable activities (the brain's dopamine system is still recalibrating)
- Anxiety, particularly in social or high-stimulus situations
- Cognitive fog — difficulty with concentration, memory, and decision-making
- Emotional dysregulation — mood swings disproportionate to external circumstances
PAWS explains the clinical observation that most opioid relapses occur not in the first days of recovery — but in the 30–90 day window after initial detox, when the patient has re-entered daily life but the brain has not yet fully healed. MAT continuation, structured outpatient programming, and peer support are the primary management strategies for the PAWS period.
Symptoms generally improve progressively over 6–18 months. Most people in sustained recovery describe marked quality-of-life improvement by the 12-month mark.
Need Opioid Detox in South Jersey? Hope Harbor Is Open 24/7.
Free, confidential assessments. Insurance accepted. Same-day intake available.
Frequently Asked Questions
For short-acting opioids (heroin, oxycodone), acute withdrawal peaks at 36–72 hours and largely resolves within 5–7 days. Long-acting opioids (methadone) can extend this to 3–4 weeks. Fentanyl, due to tissue accumulation, often produces more prolonged withdrawal than short-acting heroin. Post-acute withdrawal syndrome (PAWS) — persistent cravings and mood disruption — can continue for weeks to months beyond acute withdrawal.
Opioid withdrawal is rarely directly fatal in otherwise healthy adults — unlike alcohol or benzo withdrawal. However, it carries serious indirect risks: severe dehydration from vomiting and diarrhea, and dramatically elevated overdose risk if someone relapses during or immediately after withdrawal (lost tolerance). Medical supervision manages these risks and dramatically improves comfort and outcomes.
Yes — buprenorphine (Suboxone) eliminates most acute opioid withdrawal symptoms when properly timed and initiated. It requires careful induction — started when the patient is already in moderate withdrawal (a COWS score of 8+) to prevent precipitated withdrawal. Medical staff manage this timing safely. Suboxone can then be continued as long-term MAT if clinically indicated.
The week immediately following discharge from detox is statistically the highest-risk period for fatal overdose. Tolerance drops dramatically during detox — using the same dose that was normal before treatment can now cause respiratory arrest. This is a primary reason why step-down to PHP or IOP immediately following detox is clinically critical, not optional.
Ready to Start Recovery? Our Cherry Hill Team is Available 24/7.
Free, confidential assessments. Insurance accepted. Same-day intake available.